1. Guarner J. Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. Am J Clin Pathol. 2020;153(4):420-1. [
DOI:10.1093/ajcp/aqaa029]
2. Henry BM, De Oliveira MH, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-8. [
DOI:10.1515/cclm-2020-0369]
3. Herricks JR, Hotez PJ, Wanga V, Coffeng LE, Haagsma JA, Basáñez MG, et al. The global burden of disease study 2013: What does it mean for the NTDs?. PLoS Negl Trop Dis. 2017;11(8):e0005424. [
DOI:10.1371/journal.pntd.0005424]
4. Hajare ST, Gobena RK, Chauhan NM, Eriso F. Prevalence of intestinal parasite infections and their associated factors among food handlers working in selected catering establishments from Bule Hora, Ethiopia. BioMed Res Int. 2021;2021(1):6669742. [
DOI:10.1155/2021/6669742]
5. Daryani A, Hosseini-Teshnizi S, Hosseini SA, Ahmadpour E, Sarvi S, Amouei A, et al. Intestinal parasitic infections in Iranian preschool and school children: A systematic review and meta-analysis. Acta Trop. 2017;169:69-83. [
DOI:10.1016/j.actatropica.2017.01.019]
6. Abou-Seri HM, Abdalgaber M, Zahran F. Investigating the Potential Effects of COVID-19 Pandemic on Intestinal Coccidian Infections. J Pure Appl Microbiol. 2022;16(3):1447-64. [
DOI:10.22207/JPAM.16.3.51]
7. Geraili A, Badirzadeh A, Sadeghi M, Mousavi SM, Mousavi P, Shahmoradi Z, et al. Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran. J Parasitic Dis. 2023;47(1):185-91. [
DOI:10.1007/s12639-022-01556-5]
8. Wolday D, Tasew G, Amogne W, Urban B, Schallig HD, Harris V, et al. Interrogating the impact of intestinal parasite-microbiome on pathogenesis of COVID-19 in Sub-Saharan Africa. Front Microbiol. 2021;12:614522. [
DOI:10.3389/fmicb.2021.614522]
9. Wolday D, Gebrecherkos T, Arefaine ZG, Kiros YK, Gebreegzabher A, Tasew G, et al. Effect of co-infection with intestinal parasites on COVID-19 severity: a prospective observational cohort study. EClinicalMedicine. 2021;39:101054. [
DOI:10.1016/j.eclinm.2021.101054]
10. Abdoli A. Helminths and COVID-19 co-infections: a neglected critical challenge. ACS Pharmacol Transl Sci. 2020;3(5):1039-41. [
DOI:10.1021/acsptsci.0c00141]
11. Nakhaei M, Fakhar M, Sharifpour A, Banimostafavi ES, Zakariaei Z, Mehravaran H, et al. First co-morbidity of Lophomonas blattarum and COVID-19 infections: confirmed using molecular approach. Acta Parasitol. 2022;67:535-8. [
DOI:10.1007/s11686-021-00468-3]
12. Mewara A, Sahni N, Jain A. Considering opportunistic parasitic infections in COVID-19 policies and recommendations. Trans R Soc Trop Med Hyg. 2021;115(11):1345-7. [
DOI:10.1093/trstmh/trab142]
13. Garcia LS, Procop GW. Diagnostic Medical Parasitology. In Manual of Commercial Methods in Clinical Microbiology. eds. Truant AL, TangY-W, Waites KB, Bébéar C. New York, U.S.A.: John Wiley & Sons, Inc. 2016. pp. 284-308. [
DOI:10.1002/9781119021872.ch15]
14. Turki H, Hamedi Y, Heidari-Hengami M, Najafi-Asl M, Rafati S, Sharifi-Sarasiabi K. Prevalence of intestinal parasitic infection among primary school children in southern Iran. J Parasit Dis. 2017;41:659-65. [
DOI:10.1007/s12639-016-0862-6]
15. Mohammadi-Meskin V, Hamedi Y, Heydari-Hengami M, Eftekhar E, Shamseddin J, Sharifi-Sarasiabi K. Intestinal parasitic infections in mental retardation center of Bandar Abbas, southern Iran. Iran J Parasitol. 2019;14(2):318-25. [
DOI:10.18502/ijpa.v14i2.1145]
16. Heydari-Hengami M, Hamedi Y, Najafi-Asl M, Sharifi-Sarasiabi K. Prevalence of intestinal parasites in food handlers of Bandar Abbas, Southern Iran. Iran J Public Health. 2018;47(1):111-8.
17. Aydemir S, Afshar MT, Şahin M, Cengiz ZT, Elasan S, Barlık F, et al. The Impact of COVID-19 Pandemic on Intestinal Parasite Frequency: A Retrospective Study. Eastern J Med. 2023;28(1):82-6. [
DOI:10.5505/ejm.2023.02800]
18. Abd Al-Khaliq I, Mahdi I, Nasser A. Intestinal Parasitic Infections in Relation to COVID-19 in Baghdad City. Open Access Maced J Med Sci. 2021;9(A):532-4. [
DOI:10.3889/oamjms.2021.6622]
19. Abbaszadeh Afshar MJ, Barkhori Mehni M, Rezaeian M, Mohebali M, Baigi V, Amiri S, et al. Prevalence and associated risk factors of human intestinal parasitic infections: a population-based study in the southeast of Kerman province, southeastern Iran. BMC Infecti Dis. 2020;20:1-8. [
DOI:10.1186/s12879-019-4730-8]
20. Stauffer WM, Alpern JD, Walker PF. COVID-19 and dexamethasone: a potential strategy to avoid steroid-related Strongyloides hyperinfection. JAMA. 2020;324(7):623-4. [
DOI:10.1001/jama.2020.13170]
21. Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clinica chimica acta. 2020;510:475-82. [
DOI:10.1016/j.cca.2020.08.019]
22. Tao Z, Xu J, Chen W, Yang Z, Xu X, Liu L, et al. Anemia is associated with severe illness in COVID‐19: a retrospective cohort study. J Med Virol. 2021;93(3):1478-88. [
DOI:10.1002/jmv.26444]
23. Taghipour A, Pirestani M, Farahani RH, Barati M, Asadipoor E. Frequency, subtypes distribution, and risk factors of Blastocystis spp. in COVID-19 patients in Tehran, capital of Iran: a case-control study. New Microbes New Infect. 2023;51:101063. [
DOI:10.1016/j.nmni.2022.101063]